Ligand validation:3V4V

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3V4V designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3V4V_NAG_A_3046	77%	65%	0.086	0.923	0.56	0.77	-	-	1	0	100%	0.9333
3V4V_NAG_C_3046	73%	61%	0.09	0.917	0.55	0.95	-	1	0	0	100%	0.9333
3V4V_NAG_C_3105	51%	59%	0.083	0.833	0.55	0.99	-	2	0	0	100%	0.9333
3V4V_NAG_A_3447	46%	58%	0.09	0.821	0.45	1.13	-	1	0	0	100%	0.9333
3V4V_NAG_C_3447	39%	71%	0.086	0.789	0.54	0.57	-	-	0	0	100%	0.9333
3V4V_NAG_B_3415	32%	55%	0.112	0.784	0.53	1.18	-	1	1	0	100%	0.9333
3V4V_NAG_A_3485	20%	37%	0.125	0.726	0.41	2.03	-	3	0	0	100%	0.9333
3V4V_NAG_D_3260	16%	66%	0.101	0.666	0.57	0.74	-	-	0	0	100%	0.9333
3V4V_NAG_B_3260	10%	67%	0.135	0.638	0.62	0.66	-	-	0	0	100%	0.9333
3V4V_NAG_C_3485	6%	31%	0.14	0.559	0.48	2.2	-	5	0	0	100%	0.9333
3V4V_NAG_A_3105	4%	69%	0.122	0.504	0.56	0.64	-	-	0	0	100%	0.9333
3V4P_NAG_A_604	84%	69%	0.088	0.95	0.54	0.65	-	-	0	0	100%	0.9333
4IRZ_NAG_A_3046	41%	73%	0.108	0.821	0.53	0.51	-	-	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.